Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.
3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic.
Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.
The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
The Australian government has ordered an investigation into the sale of counterfeit face masks in the country, following warnings from health experts and local media reports over the prevalence of fake equipment.
Australian ear implants manufacturer Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation.